Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
PLOS Pathogens · 25.01.2024 · 20 (1) · e1011982
DOI: 10.1371/journal.ppat.1011982 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 25.01.2024. Verfasst von Philine Steinbach und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Influenza, Human, Orthomyxoviridae Infections, Influenza A virus, Communicable Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Influenza A virus (IAV) can cause severe respiratory infection leading to significant global morbidity and mortality through seasonal epidemics. Likewise, the constantly increasing number of cancer diseases is a growing problem. Nevertheless, the understanding of the mutual interactions of the immune responses between cancer and infection is still very vague. Therefore, it is important to understand the immunological cross talk between cancer and IAV infection. In several preclinical mouse models of cancer, including melanoma and colorectal cancer, we observed that IAV infection in the lung significantly decreased the tumour burden. Concomitantly, tumour-specific CD8 + T-cells are strongly activated upon infection, both in the tumour tissue and in the lung. CD8 + T-cell depletion during infection reverses the reduced tumour growth. Interestingly, IAV infection orchestrated the migration of tumour-specific CD8 + T-cells from the tumour into the infected lung. Blocking the migration of CD8 + T-cells prevented the anti-tumoural effect. Thus, our findings show that viral respiratory infection has significant impact on the anti-tumour CD8 + T-cell response, which will significantly improve our understanding of the immunological cross talk between cancer and infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
ORCID-Profile: Torben Knuschke
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Steinbach, P., Pastille, E., Kaumanns, L., Adamczyk, A., Sutter, K., Hansen, W., Dittmer, U., Buer, J., Westendorf, A. M., & Knuschke, T. (2024). Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control. PLOS Pathogens, 20(1), e1011982. https://doi.org/10.1371/journal.ppat.1011982
Vancouver
Steinbach P, Pastille E, Kaumanns L, Adamczyk A, Sutter K, Hansen W, et al. Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control. PLOS Pathogens. 2024;20(1):e1011982. doi:10.1371/journal.ppat.1011982
BibTeX
@article{Steinbach2024,
author = {Steinbach, Philine and Pastille, Eva and Kaumanns, Lara and Adamczyk, Alexandra and Sutter, Kathrin and Hansen, Wiebke and Dittmer, Ulf and Buer, Jan and Westendorf, Astrid M and Knuschke, Torben},
title = {Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control},
journal = {PLOS Pathogens},
year = {2024},
volume = {20},
number = {1},
pages = {e1011982},
doi = {10.1371/journal.ppat.1011982}
}
EUVIMED